X-136548847-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000370634.8(VGLL1):āc.473A>Gā(p.Glu158Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,210,548 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000370634.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL1 | NM_016267.4 | c.473A>G | p.Glu158Gly | missense_variant | 3/5 | ENST00000370634.8 | NP_057351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL1 | ENST00000370634.8 | c.473A>G | p.Glu158Gly | missense_variant | 3/5 | 1 | NM_016267.4 | ENSP00000359668.3 | ||
VGLL1 | ENST00000440515.5 | c.365A>G | p.Glu122Gly | missense_variant | 2/4 | 3 | ENSP00000398360.1 | |||
VGLL1 | ENST00000456412.1 | c.41-1921A>G | intron_variant | 3 | ENSP00000388868.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 14AN: 112283Hom.: 0 Cov.: 23 AF XY: 0.0000580 AC XY: 2AN XY: 34457
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183329Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67813
GnomAD4 exome AF: 0.0000173 AC: 19AN: 1098265Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 4AN XY: 363619
GnomAD4 genome AF: 0.000125 AC: 14AN: 112283Hom.: 0 Cov.: 23 AF XY: 0.0000580 AC XY: 2AN XY: 34457
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.473A>G (p.E158G) alteration is located in exon 3 (coding exon 2) of the VGLL1 gene. This alteration results from a A to G substitution at nucleotide position 473, causing the glutamic acid (E) at amino acid position 158 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at